Literature DB >> 26029467

Regression of hepatocellular carcinoma after treatment of hepatitis C: a case report.

Emaculate Verla-Tebit1, Osama E Rahma1.   

Abstract

Chronic hepatitis C induced cirrhosis predisposes to hepatocellular carcinoma (HCC). There is no data regarding the impact of hepatitis C treatment on HCC. We report a case of a 53-year-old man with chronic hepatitis C and HCC with lung metastasis who failed treatment with sorafenib but the tumor regressed after treatment of hepatitis C with ribavirin and sofosbuvir for 24 weeks.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); hepatitis C; ribavirin; sofosbuvir

Year:  2015        PMID： 26029467      PMCID： PMC4397252          DOI： 10.3978/j.issn.2078-6891.2014.115

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


  13 in total

1.  The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

Authors:  Joseph F Perz; Gregory L Armstrong; Leigh A Farrington; Yvan J F Hutin; Beth P Bell
Journal:  J Hepatol       Date:  2006-06-23       Impact factor: 25.083

2.  Interferon alpha and ribavirin collaboratively regulate p38 mitogen-activated protein kinase signaling in hepatoma cells.

Authors:  Sheng-Fei He; Wen Wang; Hao Ren; Lan-Juan Zhao; Zhong-Tian Qi
Journal:  Cytokine       Date:  2013-02-12       Impact factor: 3.861

3.  Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.

Authors:  Andrew X Zhu; Masatoshi Kudo; Eric Assenat; Stéphane Cattan; Yoon-Koo Kang; Ho Yeong Lim; Ronnie T P Poon; Jean-Frederic Blanc; Arndt Vogel; Chao-Long Chen; Etienne Dorval; Markus Peck-Radosavljevic; Armando Santoro; Bruno Daniele; Junji Furuse; Annette Jappe; Kevin Perraud; Oezlem Anak; Dalila B Sellami; Li-Tzong Chen
Journal:  JAMA       Date:  2014-07-02       Impact factor: 56.272

4.  Sofosbuvir for previously untreated chronic hepatitis C infection.

Authors:  Eric Lawitz; Alessandra Mangia; David Wyles; Maribel Rodriguez-Torres; Tarek Hassanein; Stuart C Gordon; Michael Schultz; Mitchell N Davis; Zeid Kayali; K Rajender Reddy; Ira M Jacobson; Kris V Kowdley; Lisa Nyberg; G Mani Subramanian; Robert H Hyland; Sarah Arterburn; Deyuan Jiang; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Aasim M Sheikh; Zobair Younossi; Edward J Gane
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

5.  Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.

Authors:  Ira M Jacobson; Stuart C Gordon; Kris V Kowdley; Eric M Yoshida; Maribel Rodriguez-Torres; Mark S Sulkowski; Mitchell L Shiffman; Eric Lawitz; Gregory Everson; Michael Bennett; Eugene Schiff; M Tarek Al-Assi; G Mani Subramanian; Di An; Ming Lin; John McNally; Diana Brainard; William T Symonds; John G McHutchison; Keyur Patel; Jordan Feld; Stephen Pianko; David R Nelson
Journal:  N Engl J Med       Date:  2013-04-23       Impact factor: 91.245

6.  A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma.

Authors:  Min-Shan Chen; Jin-Qing Li; Yun Zheng; Rong-Ping Guo; Hui-Hong Liang; Ya-Qi Zhang; Xiao-Jun Lin; Wan Y Lau
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

Review 7.  Hepatitis C virus: virology, diagnosis and management of antiviral therapy.

Authors:  Stéphane Chevaliez; Jean-Michel Pawlotsky
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

Review 8.  Role of p38 MAP Kinase Signal Transduction in Solid Tumors.

Authors:  Hari K Koul; Mantu Pal; Sweaty Koul
Journal:  Genes Cancer       Date:  2013-09

9.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

Review 10.  Sofosbuvir: a novel oral agent for chronic hepatitis C.

Authors:  Evangelos Cholongitas; George V Papatheodoridis
Journal:  Ann Gastroenterol       Date:  2014
View more
  2 in total

1.  Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma.

Authors:  Zahariy Krastev; Deian Jelev; Krasimir Antonov; Tanya Petkova; Evelina Atanasova; Nadezhda Zheleva; Bojidar Tomov; Yana Boyanova; Lyudmila Mateva
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

2.  Highlights from the 2016 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): 25-27 May, Marseille, France.

Authors:  Jean-Pierre Routy; Christina Psomas; Vicente Soriano; Patrick Philibert; Hervé Tissot-Dupont; Alain Lafeuillade
Journal:  J Virus Erad       Date:  2016-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.